1/93
Alterations in Special Sensory Function - ears, eyes
Diagnostic differentiation between conductive and sensorineural loss done with what (2)
tuning fork tests (Rinne and Weber tests)
audiometry - evaluate air conduction through external ear canal versus bone conduction through the mastoid process
Conductive Hearing Loss Primary Site of Lesion
External ear or middle ear cavity
Conductive Hearing Loss Pathophysiological Mechanism
Physical obstruction/mechanical defect blocking sound wave transmission to the inner ear
Conductive Hearing Loss Etiology (5)
Cerumen impaction, foreign bodies, tympanic membrane perforation/scarring, otitis media effusion, otosclerosis
Conductive Hearing Loss Conduction Test Profile
Impaired air conduction with preserved inner ear/bone conduction
Conductive Hearing Loss General Severity & Response
Mild to moderate deficit; frequently responds to medical or surgical removal of obstruction
Sensorineural Hearing Loss Primary Site of Lesion (3)
Inner ear (Organ of Corti/hair cells), Cranial Nerve VIII, or temporal auditory cortex
Sensorineural Hearing Loss Pathophysiological Mechanism
Failure of electrical transduction in sensory hair cells or neural impulse transmission along the auditory nerve
Sensorineural Hearing Loss Etiology (5)
Presbycusis (aging), ototoxic medications, acoustic trauma/loud noise, viral/bacterial infections, head trauma
Sensorineural Hearing Loss Conduction Test Profile
Equal impairment of both air and bone conduction
Sensorineural Hearing Loss General Severity & Response
Can cause severe to total deafness; may require hearing aids or cochlear implants
Cerumen Accumulation and Foreign Bodies relation to conductive loss
blockage of external auditory meatus prevents sound waves from reaching tympanic membrane
Tympanic Membrane Perforation and Scarring relation to conductive loss
Loss of tympanic membrane elasticity or integrity secondary to trauma or recurrent infections (such as chronic otitis media), » restricted membrane vibration
otosclerosis relation to conductive loss
inherited or acquired metabolic bone remodeling disorder where excessive bone growth fixes the stapes footplate to the oval window, preventing mechanical fluid displacement within the cochlea
Presbycusis
progressive, age-related sensorineural decline by the gradual loss of sensory hair cells and degenerative changes in the cochlea
Ototoxic meds causing sensorineural hearing loss (4)
agents that damage hair cells in the Organ of Corti or vestibular system
aminoglycoside antibiotics (e.g., streptomycin, vancomycin, neomycin), loop diuretics (e.g., furosemide), NSAIDS (e.g., high-dose aspirin, ibuprofen), and antineoplastic agents.
define Acoustic Trauma, causes which hearing loss
extremely loud noises/chronic occupational exposure to high-decibel noise » damages delicate hair cell microvilli due to excessive wave force.
sensorineural
Infections and Neurological Disorders cause what hearing loss + examples
sensorineural
viral infections (such as rubella, influenza, and herpes), bacterial meningitis, head trauma, or temporal lobe tumors that injure CN VIII
otosclerosis management
stapedectomy - remove stapes
membrane perforation treatment
tympanoplasty - repairs hole/tear
standard sensorineural loss treatment
sound-amplifying hearing aids are beneficial if functional hair cells remain
profound sensorineural loss treatment
if non-functional hair cells present
intact auditory nerve » cochlear implants surgically
Otitis media
inflammation or infection of the middle ear cavity
Otitis media common demographic
pediatrics
Over 70% of children experience at least one episode before age two
Otitis media etiology
bacterial pathogens (flu), streptococcus pneumoniae (pneumococci), beta-hemolytic streptococci, and staphylococci
Anatomical Predisposition of otitis media in Children
Eustachian (auditory) tubes are shorter, wider, and oriented more horizontally compared to adults, facilitating the migration of nasopharyngeal pathogens along the continuous mucosal lining
Otitis Media Pathophysiology*
infection » inflammatory response » exudate accumulation in middle ear » exudate exerts pressure against non-yielding tympanic membrane/structures
consecutive inflammatory edema blocks Eustachian tube » prevented normal fluid drainage to nasopharynx
immediate pain relief with otitis media
pressure rises » tympanic membrane bulges » eventual rupture » purulent discharge released into the external canal
otitis media manifestations
earache, red/bulging tympanic membrane on otoscopic exam, fever, fullness, mild CONDUCTIVE hearing loss
otalgia
earache
Mastoiditis, associated with what pathology
Spread of infection into the mastoid air cells of the temporal bone - chronic otitis media
Cholesteatoma, associated with what pathology
eroding, cyst-like mass of epithelial cells and debris that forms in the middle ear following tympanic membrane perforation, produces enzymes that destroy the bony ossicles and surrounding bone - chronic otitis media
Cholesteatoma treatment
surgical excision
otitis media treatment*
Analgesic + antipyretic therapy (acetaminophen or ibuprofen) for comfort during the initial 48 hours; targeted antibacterial therapy if bacterial infection is confirmed; decongestants to encourage Eustachian tube drainage; and surgical insertion of temporary drainage tubes through the tympanic membrane for recurrent cases.
tympanostomy/myringotomy tubes use
temp drainage tubes through tympanic membrane for recurrent causes of otisis media
Otitis externa (swimmer’s ear)
infection of the external auditory canal and pinna
Otitis Externa Etiology (4)
predominantly bacterial origin, sometimes fungal
swimming (moisture create culture medium)
mechanical irritation from cleaning ear
frequent earphone/plugs
common bacteria causing swimmer’s ear
Pseudomonas aeruginosa
Otitis Externa general manifestations
Severe localized pain, purulent discharge, external canal swelling, and mild hearing deficit
classic diagnosis to distinguish otitis externa from media
pain is markedly exacerbated by movement of the pinna or pressure on the tragus
Otosclerosis
insidious chronic middle ear disorder by an abnormal imbalance between bone resorption and bone deposition
Otosclerosis development process*
excess spongy bone develop in middle ear, fixes stapes footplate to oval window, blocks mechanical transmission of sound to cochlear fluids » conductive hearing loss
Otosclerosis common demographic
genetic disposition
young adult female
Otosclerosis treatment (2)
stapedectomy (removal of the fixed stapes and insertion of a prosthetic replacement) or laser liberation of the ossicular chain (separates inner ear structures from diseased tissue)
Ménière's Syndrome
chronic disorder of inner ear labyrinth by intermittent, excessive accumulation of endolymph fluid (endolymphatic hydrops) within the membranous labyrinth
usually unilateral
Ménière's Syndrome Epidemiology
adults 30-50
Ménière's Syndrome etiology (3)
stress, conditions altering systemic blood flow (such as hypertension), and sudden barometric pressure changes
Ménière's Syndrome pathophysiology*
distension of the endolymphatic sac stretch the membranous labyrinth » interfered hair cell function in cochlea (hearing organ) and vestibule/semicircular canals (balance organs)
fluid buildup/rupture causes perilymph and endolymph to mix, triggering acute symptomatic attacks lasting minutes to hours. repeated can cause permanent sensorineural loss/equilibrium deficits
Ménière's Syndrome symptom triad
severe vertigo, tinnitus, unilateral sensorineural hearing loss (full sensation/pressure)
Severe Vertigo
Intense whirling sensation, loss of balance, and risk of falls
Tinnitus
Subjective roaring, ringing, or buzzing noise in the affected ear
Ménière's Syndrome associated signs
Autonomic disturbance (nausea, vomiting, sweating), inability to focus, and nystagmus
nystagmus
involuntary eye movements
Ménière's Syndrome diagnostics
Balance tests (rotary-chair, video head impulse), electronystagmography (ENG), electrocochleography (ECOG), and MRI to exclude acoustic neuromas.
Ménière's Syndrome management - meds (3) and lifestyle (4)
Pharmacological suppression during attacks using dimenhydrinate (antiemetic), diazepam (vestibular depressant), and antihistamines
Long-term management includes a low-sodium diet, mild diuretics, avoidance of triggers (smoking, alcohol, caffeine), and motion-desensitization exercise programs.
rods type of vision
dim light, black-and-white vision
cones location and type of vision
concentrated at the fovea centralis within the macula lutea
acute, sharp color vision
visual pathway*
optic nerve CN II » optic chiasm (medial nasal fibers cross to the contralateral hemisphere) » optic tract » Lateral Geniculate Nucleus of Thalamus » Visual Radiations » Primary Visual Cortex
Myopia (Nearsightedness)
eyeball too elongated/focal point too strong, light rays focused in front of retina
Myopia (Nearsightedness) correction
concave lenses
Hyperopia (Farsightedness)
eyeball too short, light rays focused behind retina
Hyperopia (Farsightedness) correction
convex lenses
Presbyopia
Age-related loss of lens elasticity, reducing accommodative capacity for near vision
Astigmatism
Irregular curvature of the cornea or lens causing uneven light refraction.
Cataracts
progressive opacity or clouding of normally clear crystalline lens that impairs light transmission to the retina
cataracts causes (5)
age-related protein denaturation, metabolic disorders (e.g., chronic hyperglycemia in Diabetes Mellitus), prolonged UV light exposure, ocular trauma, congenital infections (such as maternal rubella or toxoplasmosis).
cataracts pathophysiology
Structural protein degradation within the lens fibers causes aggregation and progressive clouding
cataracts manifestations
Insidious, painless onset of blurred vision across the visual field that becomes progressively darker over time.
difficulty with glare and night driving
cataracts management
Outpatient surgical replacement (phacoemulsification)
phacoemulsification
treatment for cataracts
ultrasonic oscillations to fragment the degenerated lens material for aspiration, then insertion of a clear artificial intraocular lens (IOL).
Glaucoma*
elevated intraocular pressure from excessive accumulation of aqueous humor in the anterior cavity » optic nerve atrophy and irreversible visual field loss
normal IOP
10 and 20 mmHg
pathological IOP
IOP > 24 mmHg
Aqueous humor pathway *
secreted by the ciliary processes into the posterior chamber, flows through the pupil into the anterior chamber, and drains through the trabecular meshwork into the Canal of Schlemm for reabsorption into venous circulation.
Acute (Narrow-Angle / Closed-Angle) Glaucoma - Incidence & Onset
Less common; sudden, acute emergency onset
Acute (Narrow-Angle / Closed-Angle) Glaucoma - Anatomical Pathology
Angle between cornea and iris is pathologically narrowed; iris shifts anteriorly, completely blocking fluid outflow
Acute (Narrow-Angle / Closed-Angle) Glaucoma - Etiology
Aging, anatomical narrow angle, trauma/scar tissue; triggered by pupil dilation (mydriasis)
mydriasis
abnormal or persistent dilation (enlargement) of the pupil of the eye that fails to constrict normally in bright light
Acute (Narrow-Angle / Closed-Angle) Glaucoma - manifestations
Sudden, severe ocular pain, eye redness, cloudy cornea, severe headache, nausea, rapid visual loss
Acute (Narrow-Angle / Closed-Angle) Glaucoma - treatment
Emergency medical lowering of IOP followed by surgical/laser iridotomy (creating a drainage hole in iris)
Chronic (Open-Angle / Wide-Angle) Glaucoma - Incidence & Onset
Most common form (90%); insidious, slow, asymptomatic onset after age 50
Chronic (Open-Angle / Wide-Angle) Glaucoma - Anatomical Pathology
Degenerative trabecular meshwork thickening and Canal of Schlemm obstruction; slow fluid drainage decline
Chronic (Open-Angle / Wide-Angle) Glaucoma - causes (3)
Age-related degeneration, genetic predisposition, diabetes
Chronic (Open-Angle / Wide-Angle) Glaucoma - manifestations (3)
Painless elevation of IOP; insidious loss of peripheral vision (tunnel vision); "cupping" of optic disc
Chronic (Open-Angle / Wide-Angle) Glaucoma - treatment
Lifetime topical eye drops (beta-blockers, miotics); laser trabeculoplasty or trabeculectomy if drops fail
Retinopathy
vascular damage affecting the microcirculation of the retina, leading to tissue ischemia and visual impairment.
predominantly secondary to chronic systemic diseases
Diabetic Retinopathy and progression
hyperglycemia damages retinal capillary endothelial cells
Early non-proliferative changes include microaneurysms, flame hemorrhages, and hard lipid exudates.
ischemia worsens: proliferative stage neovascularization occurs—the growth of fragile, abnormal new blood vessels that easily rupture, bleed into the vitreous humor, and create fibrous traction leading to retinal detachment
Hypertensive Retinopathy
elevated blood pressure causes retinal arteriolar narrowing, arteriolosclerosis ("copper-wiring"), flame-shaped hemorrhages, and ischemic cotton-wool spots (nerve fiber layer infarctions).
Retinopathy diagnostic
dilated fundoscopy (back of eye fundus exam)
Retinopathy treatment
strict control of underlying hypertension and blood glucose, laser photocoagulation (to cauterize leaking vessels and destroy ischemic tissue), intravitreal anti-VEGF (vascular endothelial growth factor) injections to suppress abnormal neovascularization
Retinal Detachment
pigmented layer of the retina separates from the underlying sensory layer and vascular choroid
Retinal Detachment pathophysiology
tear/hole in retina allows vitreous humour to seep behind retinal layer and separates it from vascular choroid » ischemia and irreversible blindness if untreated
Retinal Detachment manifestations
painless onset.
sudden appearance of dark floaters, flashes of light (photopsia), followed by a progressive, dark curtain-like shadow advancing across the visual field (scotomas).
Retinal Detachment treatment
Immediate surgical reattachment (such as scleral buckling, pneumatic retinopexy, or vitrectomy) to restore retinal apposition to the choroid before permanent receptor necrosis occurs